iRhythm Technologies, Inc. (IRTC)
USD 105.92
(-2.22%)
USD 105.92
(-2.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -96.86 Million USD | -7.99% |
| 2022 | -92.13 Million USD | 14.71% |
| 2021 | -83.23 Million USD | -137.22% |
| 2020 | -29.15 Million USD | 20.39% |
| 2019 | -40.46 Million USD | -25.58% |
| 2018 | -44.95 Million USD | -61.68% |
| 2017 | -24.43 Million USD | -47.46% |
| 2016 | -17.08 Million USD | 16.91% |
| 2015 | -21.24 Million USD | -43.41% |
| 2014 | -14.81 Million USD | -34.35% |
| 2013 | -11.02 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -16.58 Million USD | 71.98% |
| 2024 Q3 | -50.3 Million USD | -255.52% |
| 2024 Q1 | -31.76 Million USD | -17.28% |
| 2023 Q4 | -21.63 Million USD | -5.89% |
| 2023 FY | - USD | -7.99% |
| 2023 Q1 | -33.13 Million USD | -73.35% |
| 2023 Q2 | -17.43 Million USD | 47.37% |
| 2023 Q3 | -20.43 Million USD | -17.18% |
| 2022 Q2 | -18.71 Million USD | -52.86% |
| 2022 Q1 | -12.24 Million USD | 61.96% |
| 2022 Q4 | -19.11 Million USD | 7.77% |
| 2022 FY | - USD | 14.71% |
| 2022 Q3 | -20.72 Million USD | -10.72% |
| 2021 Q1 | -27.34 Million USD | -194.01% |
| 2021 Q4 | -32.18 Million USD | -37.79% |
| 2021 FY | - USD | -137.22% |
| 2021 Q3 | -23.35 Million USD | -37.91% |
| 2021 Q2 | -16.93 Million USD | 38.06% |
| 2020 Q4 | -9.3 Million USD | -122.09% |
| 2020 FY | - USD | 20.39% |
| 2020 Q3 | -4.18 Million USD | 75.02% |
| 2020 Q2 | -16.76 Million USD | -93.41% |
| 2020 Q1 | -8.66 Million USD | 48.7% |
| 2019 Q1 | -7.59 Million USD | 31.58% |
| 2019 FY | - USD | -25.58% |
| 2019 Q4 | -16.89 Million USD | 7.06% |
| 2019 Q3 | -18.18 Million USD | -65.1% |
| 2019 Q2 | -11.01 Million USD | -44.93% |
| 2018 Q4 | -11.1 Million USD | -25.98% |
| 2018 FY | - USD | -61.68% |
| 2018 Q3 | -8.81 Million USD | 22.3% |
| 2018 Q2 | -11.34 Million USD | -10.59% |
| 2018 Q1 | -10.25 Million USD | 0.25% |
| 2017 Q2 | -5.6 Million USD | -25.08% |
| 2017 Q3 | -5.66 Million USD | -1.02% |
| 2017 Q4 | -10.28 Million USD | -81.65% |
| 2017 FY | - USD | -47.46% |
| 2017 Q1 | -4.48 Million USD | 17.61% |
| 2016 Q4 | -5.43 Million USD | -77.86% |
| 2016 FY | - USD | 16.91% |
| 2016 Q3 | -3.05 Million USD | 10.69% |
| 2016 Q1 | -5.1 Million USD | 26.25% |
| 2016 Q2 | -3.42 Million USD | 32.92% |
| 2015 Q2 | -4.53 Million USD | 0.0% |
| 2015 Q4 | -6.92 Million USD | -28.19% |
| 2015 Q3 | -5.39 Million USD | -19.06% |
| 2015 Q1 | -4.53 Million USD | -20.28% |
| 2015 FY | - USD | -43.41% |
| 2014 Q4 | -3.77 Million USD | 0.0% |
| 2014 FY | - USD | -34.35% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -618.188% |
| Cerus Corporation | -26.53 Million USD | -265.021% |
| OrthoPediatrics Corp. | -8.38 Million USD | -1055.733% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -822.98% |
| Talis Biomedical Corporation | -66.04 Million USD | -46.661% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -480.882% |
| Inogen, Inc. | -45.67 Million USD | -112.049% |
| Spectral AI, Inc. | -12.26 Million USD | -689.936% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -103.095% |
| CVRx, Inc. | -38.73 Million USD | -150.089% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -2645.522% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -700.05% |
| Orthofix Medical Inc. | -86.98 Million USD | -11.355% |
| Venus Concept Inc. | -26.11 Million USD | -270.934% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -94.615% |
| Bioventus Inc. | -23.07 Million USD | -319.861% |
| BrainsWay Ltd. | -2.31 Million USD | -4091.346% |
| Envoy Medical, Inc. | -18.23 Million USD | -431.1% |
| electroCore, Inc. | -17.76 Million USD | -445.394% |
| IceCure Medical Ltd | -15.25 Million USD | -535.036% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -94.694% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -474.654% |
| MaxCyte, Inc. | -44.12 Million USD | -119.502% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -723.938% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1601.709% |
| PAVmed Inc | -75.74 Million USD | -27.884% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -80.182% |
| RxSight, Inc. | -41.03 Million USD | -136.036% |
| Sight Sciences, Inc. | -49.41 Million USD | -96.017% |
| SI-BONE, Inc. | -34.44 Million USD | -181.2% |
| TELA Bio, Inc. | -40.63 Million USD | -138.383% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -66.15% |
| Treace Medical Concepts, Inc. | -39 Million USD | -148.313% |
| LivaNova PLC | 39.01 Million USD | 348.262% |
| 908 Devices Inc. | -34.02 Million USD | -184.679% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 12.415% |
| Nemaura Medical Inc. | -7.28 Million USD | -1229.233% |
| NeuroPace, Inc. | -22.83 Million USD | -324.201% |
| LENSAR, Inc. | -8.71 Million USD | -1011.568% |
| Apyx Medical Corporation | -18.11 Million USD | -434.795% |
| Cutera, Inc. | -136.56 Million USD | 29.071% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -2765.74% |
| BioSig Technologies, Inc. | -28.15 Million USD | -244.08% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 3949.841% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -361.489% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 125.253% |
| Axonics, Inc. | 7.77 Million USD | 1345.814% |
| Outset Medical, Inc. | -153.78 Million USD | 37.016% |
| IRIDEX Corporation | -7.44 Million USD | -1200.51% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 1.257% |
| IRadimed Corporation | 20.8 Million USD | 565.668% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -1101.464% |
| INVO Bioscience, Inc. | -6.88 Million USD | -1307.873% |
| Telesis Bio, Inc. | -40.49 Million USD | -139.207% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 364.095% |
| Varex Imaging Corporation | 67.2 Million USD | 244.14% |
| Quipt Home Medical Corp. | 44.07 Million USD | 319.786% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -791.095% |
| Pulmonx Corporation | -55.09 Million USD | -75.819% |
| Dynatronics Corporation | -976 Thousand USD | -9824.304% |
| Modular Medical, Inc. | -17.1 Million USD | -466.345% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -568.706% |
| Semler Scientific, Inc. | 23.58 Million USD | 510.624% |
| InMode Ltd. | 196.28 Million USD | 149.348% |
| Bruker Corporation | 599 Million USD | 116.171% |
| Cytosorbents Corporation | -28.81 Million USD | -236.2% |
| DexCom, Inc. | 916.7 Million USD | 110.566% |
| Align Technology, Inc. | 799.03 Million USD | 112.122% |
| Viveve Medical, Inc. | -20.61 Million USD | -369.816% |
| ZimVie Inc. | 91.07 Million USD | 206.356% |
| Movano Inc. | -29.12 Million USD | -232.573% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -2097.414% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1601.709% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -2645.522% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 50.24% |
| Profound Medical Corp. | -27.12 Million USD | -257.115% |
| Insulet Corporation | 323.6 Million USD | 129.933% |
| enVVeno Medical Corporation | -25.01 Million USD | -287.169% |
| Surmodics, Inc. | 1.18 Million USD | 8253.367% |
| iCAD, Inc. | -6.56 Million USD | -1375.43% |
| Nuwellis, Inc. | -16.35 Million USD | -492.211% |
| Biotricity, Inc. | -8.82 Million USD | -997.18% |
| Aethlon Medical, Inc. | -11.84 Million USD | -717.462% |
| InspireMD, Inc. | -20.91 Million USD | -363.211% |
| PAVmed Inc. | -75.74 Million USD | -27.884% |
| BIOLASE, Inc. | -15.13 Million USD | -539.818% |
| Beyond Air, Inc. | -59.03 Million USD | -64.087% |
| FONAR Corporation | 28.25 Million USD | 442.855% |
| AxoGen, Inc. | -13.32 Million USD | -626.756% |
| Vivani Medical, Inc. | -26.6 Million USD | -264.033% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 494.695% |
| Inari Medical, Inc. | 7.11 Million USD | 1461.76% |
| UFP Technologies, Inc. | 72.74 Million USD | 233.156% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -2760.842% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -1473.458% |
| Tenon Medical, Inc. | -15.52 Million USD | -523.789% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -534.495% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -133.539% |
| AdaptHealth Corp. | -171.09 Million USD | 43.386% |
| Sintx Technologies, Inc. | -6.6 Million USD | -1367.606% |
| NanoVibronix, Inc. | -3.43 Million USD | -2719.854% |
| Quanterix Corporation | -38.08 Million USD | -154.311% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -791.095% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 322973.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 65.067% |
| TransMedics Group, Inc. | -7.6 Million USD | -1173.997% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -345.036% |
| NeuroMetrix, Inc. | -7.09 Million USD | -1265.059% |
| Hyperfine, Inc. | -47.06 Million USD | -105.822% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -66.124% |
| Biomerica, Inc. | -5.99 Million USD | -1516.252% |
| Bone Biologics Corporation | 479.57 Thousand USD | 20297.593% |
| AVITA Medical, Inc. | -39.56 Million USD | -144.8% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -955.955% |
| Silk Road Medical, Inc | -45.08 Million USD | -114.867% |